Literature DB >> 10639702

An additional dose of cefazolin for intraoperative prophylaxis.

H Ohge1, Y Takesue, T Yokoyama, Y Murakami, E Hiyama, Y Yokoyama, T Kanehiro, H Itaha, Y Matsuura.   

Abstract

We examined the pancreatic tissue concentrations of cefazolin in ten patients undergoing pancreatectomy, and determined the optimal intraoperative time to deliver a repeat dose of cefazolin. An intravenous bolus dose of 1 g cefazolin was administered at the time of skin incision. Peripheral blood, subcutaneous adipose tissue, and peritoneal samples were obtained intraoperatively every hour for 4 h after the antibiotic was first administered, and pancreatic tissue samples were obtained at the time of pancreatectomy. To determine adequate tissue levels of cefazolin, minimum inhibitory concentrations (MIC) were measured for four bacterial species, namely 360 isolates of methicillin-sensitive Staphylococcus aureus (MSSA), 204 isolates of Klebsiella pneumoniae, 314 isolates of Escherichia coli, and 30 isolates of Streptococcus spp. The antibiotic concentrations in adipose tissue and peritoneum 3 h after the administration of cefazolin were lower than the MIC80 for K. pneumoniae, E. coli, and Streptococcus spp. Most pancreatic tissue samples showed antibiotic concentrations greater than the MIC80 for these bacterial species; however, those from four patients complicated by severe chronic pancreatitis, massive intraoperative bleeding, or obesity showed concentrations lower than the MIC80. Thus, we recommend that a second dose of cefazolin be given 3 h after the first administration to maintain adequate levels of antibiotic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10639702     DOI: 10.1007/BF02482213

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

Review 1.  Pharmacodynamics of antibiotic penetration of tissue and surgical prophylaxis.

Authors:  T M Bergamini; H C Polk
Journal:  Surg Gynecol Obstet       Date:  1989-03

2.  The effective period of preventive antibiotic action in experimental incisions and dermal lesions.

Authors:  J F Burke
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

3.  Human intradiscal levels with cefazolin.

Authors:  J B Boscardin; J C Ringus; D J Feingold; S C Ruda
Journal:  Spine (Phila Pa 1976)       Date:  1992-06       Impact factor: 3.468

4.  Pharmacokinetics and tissue concentrations of cefazolin in pediatric patients undergoing gastrointestinal surgery.

Authors:  M C Nahata; D E Durrell; M E Ginn-Pease; D R King
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

5.  Risk factors for infection at the operative site after abdominal or vaginal hysterectomy.

Authors:  M Shapiro; A Muñoz; I B Tager; S C Schoenbaum; B F Polk
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

6.  Antibiotic activity in surgical incisions. The basis of prophylaxis in selected operations.

Authors:  H C Polk; L Trachtenberg; M P Finn
Journal:  JAMA       Date:  1980-09-19       Impact factor: 56.272

  6 in total
  7 in total

1.  Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

Authors:  Simone van Kralingen; Margot Taks; Jeroen Diepstraten; Ewoudt M van de Garde; Eric P van Dongen; Marinus J Wiezer; Bert van Ramshorst; Bart Vlaminckx; Vera H Deneer; Catherijne A Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2011-04-16       Impact factor: 2.953

Review 2.  Body mass index and outcomes from pancreatic resection: a review and meta-analysis.

Authors:  Andrew M Ramsey; Robert C Martin
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

3.  Antimicrobial Prophylaxis Redosing Reduces Surgical Site Infection Risk in Prolonged Duration Surgery Irrespective of Its Timing.

Authors:  Daniela Bertschi; Walter P Weber; Jasmin Zeindler; Daniel Stekhoven; Robert Mechera; Lilian Salm; Marco Kralijevic; Savas D Soysal; Marco von Strauss; Edin Mujagic; Walter R Marti
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

4.  Population Pharmacokinetic and Pharmacodynamic Target Attainment Analysis of Cefazolin in the Serum and Hip Joint Capsule of Patients Undergoing Total Hip Arthroplasty.

Authors:  Toshiaki Komatsu; Yui Natsume; Katsufumi Uchiyama; Shinsuke Ikeda; Yoshinori Tomoda; Yoko Takayama; Masashi Takaso; Hideaki Hanaki; Koichiro Atsuda
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

5.  Applying surgical antimicrobial standards in cesarean deliveries.

Authors:  Kathryn E Fay; Lynn Yee
Journal:  Am J Obstet Gynecol       Date:  2018-01-17       Impact factor: 8.661

6.  Assessment of prophylactic antibiotic use in patients with surgical site infections.

Authors:  Whitney J Goede; Jenna K Lovely; Rodney L Thompson; Robert R Cima
Journal:  Hosp Pharm       Date:  2013-07

7.  Multicenter phase II study of antimicrobial prophylaxis in low-risk patients undergoing distal gastrectomy for gastric cancer.

Authors:  Hiroshi Imamura; Hiroshi Furukawa; Shohei Iijima; Seichi Sugihara; Toshimasa Tsujinaka; Hideaki Tsukuma; Toshio Shimokawa
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.